ICU MEDICAL INC/DE Cost of Revenue
ICU MEDICAL INC/DE (ICUI) reported Cost of Revenue of $1.41 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-02-19
- ICU MEDICAL INC/DE cost of goods and services sold for fiscal 2025 was $1.41B, a 9.51% decline from fiscal 2024.
- ICU MEDICAL INC/DE cost of goods and services sold for fiscal 2024 was $1.56B, a 2.50% increase from fiscal 2023.
- ICU MEDICAL INC/DE cost of goods and services sold for fiscal 2023 was $1.52B, a 3.98% decline from fiscal 2022.
- ICU MEDICAL INC/DE cost of goods and services sold for fiscal 2022 was $1.58B, a 91.83% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 12 month |
|---|---|
| 2025-12-31 | $1.41B 10-K · filed 2026-02-19 |
| 2024-12-31 | $1.56B 10-K · filed 2026-02-19 |
| 2023-12-31 | $1.52B 10-K · filed 2026-02-19 |
| 2022-12-31 | $1.58B 10-K · filed 2025-02-27 |
| 2021-12-31 | $824.82M 10-K · filed 2024-02-27 |
| 2020-12-31 | $809.51M 10-K · filed 2023-02-27 |
| 2019-12-31 | $794.34M 10-K · filed 2022-02-25 |
| 2018-12-31 | $830.01M 10-K · filed 2021-02-26 |
| 2017-12-31 | $866.52M 10-K · filed 2020-03-02 |
| 2016-12-31 | $177.97M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |